151 material Form 8-K filings that 136 companies we cover made with the SEC in February 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Avista reported 2023 full-year earnings of $2.24 per diluted share, up from $2.12 in 2022, and fourth-quarter EPS of $1.08, up from $1.05. The company also initiated 2024 consolidated EPS guidance of $2.36 to $2.56, with Avista Utilities contributing most of the expected earnings. Results and guidance point in a favorable direction for shareholders.
2023 total net income was $171.2 million, up from $155.2 million in 2022
Avista Utilities earnings per diluted share rose to $2.18 for 2023 from $1.61 in 2022
2024 guidance: consolidated $2.36 to $2.56 per diluted share; Avista Utilities $2.23 to $2.39
Company expects long-term earnings growth of 4 to 6 percent off a 2025 base year
RingCentral reported fourth-quarter 2023 total revenue of $571 million, up 9% year over year, and a GAAP net loss of $0.50 per share, compared with $2.97 a year earlier. Non-GAAP diluted EPS rose to $0.86 from $0.60, and the company gave full-year 2024 total revenue guidance of $2.370 billion to $2.395 billion with non-GAAP EPS of $3.50 to $3.58. Net cash from operating activities in the quarter was $114 million, which the company called a record for a fourth quarter.
Q4 2023 total revenue was $571 million, up from $525 million, a 9% increase.
GAAP operating loss narrowed to ($45) million from ($256) million; non-GAAP operating margin was 20.5%.
Q4 2023 net cash provided by operating activities was a record $114 million; cash and cash equivalents ended the quarter at $222 million.
FY2024 guidance: total revenue of $2.370 to $2.395 billion and non-GAAP EPS of $3.50 to $3.58.
JBG SMITH reported fourth-quarter and full-year 2023 results on February 20, 2024. The company posted a full-year net loss of $80.0 million, or $0.78 per diluted share, compared with net income of $85.4 million, or $0.70 per share, in 2022, after $90.2 million of real estate impairment losses. Core FFO per diluted share rose to $1.46 from $1.30, and the management letter says the Board reduced the annual dividend rate to $0.70.
Full-year 2023 net loss of $80.0 million ($0.78 per diluted share) vs. net income of $85.4 million ($0.70) in 2022
Full-year 2023 Core FFO of $154.1 million ($1.46 per diluted share) vs. $155.3 million ($1.30) in 2022
Fourth-quarter Core FFO of $36.1 million ($0.38 per diluted share) vs. $34.3 million ($0.30) a year earlier
Board reduced the annual dividend rate to $0.70, as stated in the management letter dated February 20, 2024
Greenwich LifeSciences dismissed MaloneBailey LLP as its independent registered public accounting firm and engaged RBSM LLP to audit its financial statements for the year ended December 31, 2023. The filing states that MaloneBailey's reports for 2021 and 2022 contained no adverse opinion, disclaimer, or qualification, but notes material weaknesses in internal control over financial reporting disclosed in prior filings. The change is administrative in nature, though the disclosed material weaknesses are relevant to shareholders.
Audit committee approved the dismissal of MaloneBailey LLP and the engagement of RBSM LLP on February 14, 2024
MaloneBailey was informed of its dismissal on February 15, 2024, effective immediately
MaloneBailey's reports for 2021 and 2022 had no adverse opinion, disclaimer, or qualification
Material weaknesses in internal control were disclosed in the 2022 and 2021 Form 10-K filings and in 2023 Form 10-Q filings; no disagreements with MaloneBailey are reported
Boise Cascade reported fourth-quarter 2023 net income of $97.5 million, or $2.44 per diluted share, down from $117.4 million, or $2.95, a year earlier, on sales of $1.6 billion, up 1%. For full-year 2023, net income fell 44% to $483.7 million ($12.12 per share) on sales down 18% to $6.8 billion, and the company also disclosed that its Wood Products executive vice president is retiring and has been succeeded.
Q4 2023 net income $97.5 million vs. $117.4 million in Q4 2022; diluted EPS $2.44 vs. $2.95
Full-year 2023 net income $483.7 million vs. $857.7 million in 2022; diluted EPS $12.12 vs. $21.56
Mike Brown, EVP Wood Products, retiring effective May 3, 2024; Troy Little appointed EVP Wood Products effective February 19, 2024, with a $540,000 base salary
2024 capital expenditures expected to total approximately $250 million to $270 million, excluding potential acquisition spending
National Presto reported 2023 net sales of $340.9 million, up 6.0%, and net earnings of $34.6 million ($4.86 per share), up from $20.7 million ($2.92 per share) in 2022. The Board also declared a 2024 dividend of $1.00 regular plus $3.50 extra per share, and disclosed two Defense segment awards totaling $44.2 million.
Net sales rose to $340.9 million from $321.6 million, led by a $39.2 million increase in Defense segment sales.
Net earnings were $34.6 million ($4.86 per share), compared with $20.7 million ($2.92 per share) in 2022.
2024 dividend is $1.00 regular plus $3.50 extra per share; record date March 1, 2024, payment date March 15, 2024.
Two Defense awards totaling $44.2 million cover 40mm cartridges for Ukraine and Small Diameter Bomb warheads, with completion scheduled for 2024.
Tootsie Roll reported fourth-quarter 2023 net sales of $195.4 million, up 4% from a year earlier, and net earnings of $29.4 million, with earnings per share of $0.42 versus $0.36. For the full year, net sales rose 12% to $763.3 million and earnings per share were $1.32 versus $1.07. Management said significantly higher input costs offset much of the benefit of the higher sales, and that margins have not yet returned to historical levels.
Q4 2023 net sales were $195,368,000 versus $188,180,000 in Q4 2022, an increase of 4%.
Q4 2023 net earnings were $29,403,000 versus $25,344,000; EPS was $0.42 versus $0.36, up 17%.
Full-year 2023 net sales were $763,252,000, up 12%; net earnings were $91,912,000 and EPS was $1.32 versus $1.07.
Management said higher ingredient, packaging and labor costs offset much of the sales benefit, and gross profit margins have not yet been restored to historical levels.
UFP Industries reported fourth-quarter 2023 net sales of $1.5 billion, down 20% from a year earlier, and diluted earnings per share of $1.62, down from $2.10. Fiscal 2023 diluted EPS was $8.07, down 26%, and management expects softer demand and a more competitive price environment in the first half of 2024, while raising its five-year unit growth and profitability goals.
Q4 2023 net sales were $1.52 billion, down 20%, driven by a 10% decline in prices and a 10% decline in organic unit sales.
Q4 2023 net earnings attributable to controlling interest were $103 million, with diluted EPS of $1.62 versus $2.10 in Q4 2022.
Fiscal 2023 net sales were $7.2 billion, down 25%, with diluted EPS of $8.07.
The board approved a quarterly dividend of $0.33 per share, payable March 15, 2024, up 10% from $0.30.
Visteon reported fourth-quarter and full-year 2023 results, with full-year net sales of $3.95 billion, up 5%, and record adjusted EBITDA of $434 million. Fourth-quarter net sales fell to $990 million from $1.06 billion, and fourth-quarter net income of $366 million included a $313 million non-cash U.S. tax benefit. The company also guided 2024 sales of $4.0 billion to $4.2 billion and adjusted EBITDA of $470 million to $500 million, and extended CEO Sachin Lawande's employment agreement through September 30, 2030.
Full-year 2023 net sales of $3.95 billion, up 5%; full-year net income of $486 million, or $17.05 per diluted share
Fourth-quarter net sales of $990 million, down from $1,064 million a year earlier, mainly due to lower semiconductor supply recoveries
2024 guidance: sales of $4.0 billion to $4.2 billion, adjusted EBITDA of $470 million to $500 million, adjusted free cash flow of $155 million to $185 million
Employment agreement with CEO Sachin Lawande extended to September 30, 2030; base salary set at $1,150,000 effective April 1, 2024
Donnelley Financial Solutions reported fourth-quarter 2023 net sales of $176.5 million, up 5.2% from a year earlier, but diluted EPS was $0.35 versus $0.36. For the full year, net sales were $797.2 million, down from $833.6 million, and diluted EPS was $2.69 versus $3.17, so profit declined even as the company cited growth in software solutions. The company also authorized a new $150 million buyback and said a new SEC shareholder report rule is expected to be slightly dilutive to 2024 earnings before adding to 2025.
Q4 2023 net sales of $176.5 million, up from $167.7 million; Q4 diluted EPS $0.35 versus $0.36 in Q4 2022
Full-year 2023 net sales of $797.2 million versus $833.6 million in 2022; full-year diluted EPS $2.69 versus $3.17
Full-year 2023 Adjusted EBITDA of $207.4 million, a 26.0% margin, versus $218.3 million in 2022
New buyback of up to $150 million from January 1, 2024 through December 31, 2025; TSR rule expected to add $20 million to $25 million in annual net sales in 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.